***News Out***
biz.yahoo.com
Thursday September 17, 1:47 pm Eastern Time
Company Press Release
ADGI Announces Distribution Agreement With Cataldi Enterprise
HICKORY, N.C.--(BUSINESS WIRE)--Sept. 17, 1998--American Diversified Group (Nasdaq:ADGI - news) announced Thursday an agreement with Cataldi Enterprise Inc., a New York corporation, having offices in Great Neck, N.Y. and related offices in Rio de Janeiro, Brazil.
Cataldi Enterprise has been granted the rights to represent ADGI, and distribute and sell ADGI's products, both in Brazil and internationally.
Cataldi Enterprise will be instrumental in the process of securing the registration for ADGI of the Hepatitis B vaccine--SHANVAC-B, manufactured by Shantha Biotechnics Pvt. Ltd. ADGI previously announced that Shantha has granted ADGI exclusive rights to distribute the SHANVAC-B vaccine, that prevents humans from contracting Hepatitis B, throughout South America, Asia and Africa.
Cataldi Enterprise has developed a record of excellent performance and international sales expertise, world-wide, with respect to the distribution and sale of medical and pharmaceutical products, among others.
For further information, ADGI's Broadcast Fax System provides ADGI information (releases, newsletters, shareholder updates) and is accessible to all ADGI shareholders via fax. To become part of ADGI's Broadcast System, please contact ADGI's Investor Relations Office at 212/332-5009 or by fax at 212/332-3249.
Except for the historical information herein, the matters discussed in this press release include forward-looking statements that may involve a number of risks and uncertainties. Actual results may vary based upon a number of factors, including, but not limited to, risks in product and technology development, market acceptance of new products and continuing demand, the impact of competitive products and pricing, changing economic conditions and other risk factors detailed in the company's most recent annual report and other filings with the Securities and Exchange Commission.
Contact:
American Diversified Group Inc., New York
Investor Relations, 212/332-5009 |
